NAV16/05/2024 Var.+0.0900 Type of yield Focus sugli investimenti Società d'investimento
27.2400USD +0.33% reinvestment Equity Worldwide FIL IM (LU) 

Investment strategy

The fund aims to achieve capital growth over the long term. The fund invests at least 70% (and normally 75%) of its assets, in equities of companies that are involved in design, manufacture or sale of products and services in connection with health care, medicine or biotechnology from anywhere in the world. The fund may also invest in money market instruments on an ancillary basis. The fund invests at least 70% of its assets in securities of issuers with favourable environmental, social and governance (ESG) characteristics and up to 30% in securities of issuers with improving ESG characteristics. In actively managing the fund, the Investment Manager considers growth and valuation metrics, company financials, return on capital, cash flows and other measures, as well as company management, industry, economic conditions, and other factors. The Investment Manager also considers ESG characteristics when assessing investment risks and opportunities. In determining favourable ESG characteristics, the Investment Manager takes into account ESG ratings provided by Fidelity or external agencies. Through the investment management process, the Investment Manager aims to ensure that investee companies follow good governance practices. The fund assesses the ESG characteristics of at least 90% of its assets. When selecting investments, the fund"s investment universe will be reduced by at least 20% after excluding issuers based on their ESG characteristics. The fund adheres to the Fidelity Sustainable Family of Funds standards.
 

Investment goal

The fund aims to achieve capital growth over the long term. The fund invests at least 70% (and normally 75%) of its assets, in equities of companies that are involved in design, manufacture or sale of products and services in connection with health care, medicine or biotechnology from anywhere in the world. The fund may also invest in money market instruments on an ancillary basis. The fund invests at least 70% of its assets in securities of issuers with favourable environmental, social and governance (ESG) characteristics and up to 30% in securities of issuers with improving ESG characteristics.
 

Dati master

Type of yield: reinvestment
Fondi Categoria: Equity
Region: Worldwide
Settore: Sector Health / Pharma
Benchmark: MSCI ACWI Health Care Index (Net)
Business year start: 01/05
Ultima distribuzione: -
Banca depositaria: Brown Brothers Harriman (Lux) S.C.A.
Domicilio del fondo: Luxembourg
Permesso di distribuzione: Austria, Germany, Switzerland
Gestore del fondo: Alex Gold
Volume del fondo: 1.58 bill.  EUR
Data di lancio: 27/03/2013
Investment focus: -

Condizioni

Sovrapprezzo emissione: 5.25%
Tassa amministrativa massima: 1.50%
Investimento minimo: 2,500.00 USD
Deposit fees: 0.35%
Redemption charge: 0.00%
Prospetto semplificato: Download (Print version)
 

Società d'investimento

Funds company: FIL IM (LU)
Indirizzo: Kärntner Straße 9, Top 8, 1010, Wien
Paese: Austria
Internet: www.fidelity.at
 

Attività

Stocks
 
98.76%
Mutual Funds
 
1.21%
Altri
 
0.03%

Paesi

United States of America
 
61.77%
Denmark
 
9.72%
United Kingdom
 
9.46%
Switzerland
 
6.61%
France
 
4.61%
Ireland
 
3.89%
Belgium
 
1.68%
Japan
 
1.03%
Altri
 
1.23%

Filiali

Pharma/Biotechnology
 
34.75%
Healthcare services
 
33.55%
Healthcare appliances
 
25.04%
Parma, wholesale
 
2.21%
Clothing
 
1.70%
grooming products
 
1.51%
Altri
 
1.24%